Trial Profile
Carboplatin and TS-1 combination chemotherapy in cancer of unknown primary site : a phase II multicenter trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2022
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 11 Sep 2022 Status changed from active, no longer recruiting to completed.
- 09 Sep 2019 Status changed from recruiting to active, no longer recruiting.
- 23 Sep 2016 New trial record